Prosecution Insights
Last updated: August 16, 2026
Application No. 18/013,951

Electrochemical Biosensors for Rapid and Sensitive Detection of Pathogens and Pathogenic Biomarkers

Non-Final OA §103§112
Filed
Dec 30, 2022
Priority
Jul 02, 2020 — provisional 63/047,368 +3 more
Examiner
KAUR, GURPREET
Art Unit
1759
Tech Center
1700 — Chemical & Materials Engineering
Assignee
University of Pittsburgh
OA Round
3 (Non-Final)
65%
Grant Probability
Favorable
3-4
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 65% — above average
65%
Career Allowance Rate
509 granted / 782 resolved
At TC average
Strong +36% interview lift
Without
With
+36.2%
Interview Lift
resolved cases with interview
Typical timeline
3y 5m
Avg Prosecution
24 currently pending
Career history
806
Total Applications
across all art units

Statute-Specific Performance

§101
1.5%
-38.5% vs TC avg
§103
52.8%
+12.8% vs TC avg
§102
17.9%
-22.1% vs TC avg
§112
22.0%
-18.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 782 resolved cases

Office Action

§103 §112
DETAILED ACTION Status of the Claims 1. Claims 1, 2, 5, 7, 10, 11, 14, 16, 18, 20, 23 and 25 are being examined in this application. Continued Examination Under 37 CFR 1.114 2. A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 6/30/2026 has been entered. Status of the Rejections 3. Rejection of claims 5 and 7 rejected under 35 U.S.C. 112(d) or pre-AIA 35 U.S.C. 112, 4th paragraph is withdrawn in view of applicant’s arguments. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. 4. Claim(s) 1, 2, 5, 7, 10, 11, 14, 16, 18, 23 and 25 is/are rejected under 35 U.S.C. 103 as being unpatentable over Yang et al. (Sensors and Actuators B, 2016, 600-606) in view of Soleymani et al. (WO2010/025547). Claims 1, 5 and 11. Yang et al. teach a method of preparing a functionalized electrode (see section Micro-electrode array fabrication and Formulation of Microelectrode array biosensor on pages 3 and 5), comprising: depositing a conductive material onto the surface of a substrate by droplet-based printing, of particles comprising an electrically-conductive material (aerosol jet printing of silver nanoparticle ink (reads on protuberances) onto transparent glass slide as substrate; see section Micro-electrode array fabrication on page 3), and functionalizing the surface of the conductive material with a binding reagent that binds to an analyte (functionalized the silver nanoparticles with glucose oxidase; Formulation of Microelectrode array biosensor on page 5). Yang et al. teach size of nanoparticles is of about 30-50 nm (see section Micro-electrode array fabrication on page 3) but do not teach nanoparticles/protuberances having a height of at least 75 microns, wherein the height of the plurality of protuberances is at least 3x larger than diameter of a protuberance of the plurality of the protuberances. However, Soleymani et al. teach nanostructured electrodes for biosensing devices wherein the nanostructures could have variety of shapes such as CNT, fiber or hemispherical and comprised of noble metals having height in the range of about 0.5 to 100 microns and diameter in the range of 1 to about 10 microns (page 3, ll. 13-31). Therefore, it would have been obvious to one of ordinary skill in the art to substitute nanoparticles of Yang et al. with wire-like or nanotube shaped nanostructures because simple substitution of one known element for another is likely to be obvious when predictable results, nanostructure functionalized electrode, are achieved (see MPEP § 2143, B.). Combined teachings of Yang et al. and Soleymani et al. do not explicitly teach wherein the height of the plurality of protuberances is at least 3x larger than diameter of a protuberance of the plurality of the protuberances. However, in the case where the claimed ranges “overlap or lie inside ranges disclosed by the prior art” a prima facie case of obviousness exists (see MPEP 2144.05 I), thus a prima facie case of obviousness exists for constructing nanostructure/protuberances in the claimed range over the ranges disclosed by the prior art. Claim 2. Yang et al. in view of Soleymani et al. teach the protuberances have a diameter of not greater than 10 millimeter (Soleymani et al. teach diameter in the range of 1 to about 10 microns (page 3, ll. 13-31) and the area of the substrate comprising the protuberances is less than or equal to 200 square millimeter (mm2) and comprise at least one protuberance per mm2 (Yang et al. teach surface area of 15X 30 um2 which is less than or equal to 200 square millimeter (mm2) and comprise at least one nanostructure therein; see conclusion). Claim 7. Modified Yang et al. teach the particles are nanoparticles having a diameter of at least 4 nanometers to not greater than 1 micron (particles are nanostructures having diameter of about 1 microns (page 3, ll. 13-31). Claim 10. Yang et al. teach the droplets comprise a solvent, and substrate is maintained at a temperature of 50°C or greater during the deposition of the protuberances to evaporate the solvent (solvent based nanoparticles (reads on protuberances) with droplet size were deposited; see Micro-Electrode Array Fabrication on page 3 and during printing platen temperature was set to 80oC; see Additive Fabrication of Micro electrode; see page 4). Claim 14. Modified Yang et al. teach the protuberances are individual pillars having a height ranging from 1 micron to 1000 micron and diameter ranging from 0.1 microns to 500 microns (Soleymani et al. teach height in the range of about 0.5 to 100 microns and diameter in the range of 1 to about 10 microns; page 3, ll. 13-31). Claim 16. Yang et al. teach the protuberances form an open cell lattice (see Fig 2b). Claim 18. Yang et al. teach sintering the deposited conductive material (sintering was performed after deposition of silver; see page 4, Additive Fabrication of Micro-Scale Polymer Trace). Examiner is construing the limitation of “optionally at a temperature above 100oC for at least 10 minutes” to be an optional method step in the method claim and not a required step of the claimed method. Claim 23. Yang et al. teach coating the deposited conductive material with a linking molecule comprising a first portion, a second portion, and a linking portion, wherein the first portion of the linking molecule comprises a functional group for attachment of the linking molecule to the surface of the protuberance, the second portion comprises a functional group for attachment of the linking molecule to the binding reagent, and the linking portion of the molecule extends between the first portion and the second portion (glutaraldehyde is used to immobilize glucose oxidase; see page 5, glutaraldehyde inherently comprised of first portion as first aldehyde group, carbon chain as linking portion and second portion as second aldehyde group). Claim 25. Yang et al. teach reacting the second portion of the linking molecule with the binding reagent, to link the binding reagent to the deposited conductive material (glucose oxidase teach immobilize to electrode via glutaraldehyde, see page 5, i.e. second portion of glutaraldehyde connects the glucose oxidase to the electrode). Examiner is construing the limitation of “binding agent optionally comprises: a protein, such as lectin, an antibody or an antibody fragment…..” to be an optional and not a required for the claimed method. 5. Claim(s) 20 is/are rejected under 35 U.S.C. 103 as being unpatentable over Yang et al. and Soleymani et al. as applied to claim 1 above, and further in view of Cantu et al. (Sensors 2018, 3719). Claim 20. Yang et al. Soleymani et al. do not teach coating the deposited conductive material with an electrically active material such as carbon nanotubes. However, Cantu et al. teach aerosol jet printing to design and fabricate electrochemical sensor (see abstract) comprised of printing additional layer of multiwall carbon nanotubes (MWCNT) over carbon working electrode to increase surface area for biofunctionalization of the electrode and improve electronic performance (see section 2.1). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the invention in view of Cantu et al. teaching to print layer of MWCNT’s onto the conductive material of Yang et al. because the MWCNT’s would provide increase in surface area of the electrode for biofunctionalization of the electrode with glucose oxidase and thereby increase performance of the sensor. Response to Arguments Applicant's arguments filed 6/30/2026 have been fully considered but they are not persuasive. Applicant argues that Yang teaches the array disclosed are flat, two dimensional and do not teach droplet-based printing as claimed. In response, applicant disclose aerosol jet printing method of fabricating electrode by spraying the substrate with silver nanoparticles of size about 30-50 nm, thus the disclosed aerosol jet printing is droplet-based printing. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Kumar et al. (WO2009/105045) teach jet printing ink for forming nanostructure such as CNT, metal nanoparticles, needles and biofunctionalized the particles. Any inquiry concerning this communication or earlier communications from the examiner should be directed to GURPREET KAUR whose telephone number is (571)270-7895. The examiner can normally be reached M-F 9:30-6. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Curtis Mayes can be reached at 571-272-1234. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /GURPREET KAUR/ Primary Examiner Art Unit 1759
Read full office action

Prosecution Timeline

Dec 30, 2022
Application Filed
Sep 05, 2025
Non-Final Rejection mailed — §103, §112
Nov 25, 2025
Response Filed
Mar 04, 2026
Final Rejection mailed — §103, §112
Jun 30, 2026
Request for Continued Examination
Jul 01, 2026
Response after Non-Final Action
Aug 04, 2026
Non-Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12693260
ACETONE SENSOR AND ASSOCIATED METHODS
2y 11m to grant Granted Jul 28, 2026
Patent 12693256
ANALYTE SENSORS AND METHODS FOR IMPROVING INTERFERENT REJECTION AND LONGEVITY
2y 4m to grant Granted Jul 28, 2026
Patent 12687515
GAS SENSOR AND CASING FOR CONTAINING SENSOR ELEMENT
3y 4m to grant Granted Jul 21, 2026
Patent 12662577
TEMPERATURE-INSENSITIVE MEMBRANE MATERIALS AND ANALYTE SENSORS CONTAINING THE SAME
3y 2m to grant Granted Jun 23, 2026
Patent 12653430
INTERFERENCE REJECTION MEMBRANES COMPRISING CROSSLINKED POLY(VINYL ALCOHOL) MATRICES FOR IMPLANTABLE GLUCOSE SENSORS
4y 7m to grant Granted Jun 16, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
65%
Grant Probability
99%
With Interview (+36.2%)
3y 5m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 782 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month